Join Amazon Prime and ship Two-Day for free and Overnight for $3.99. Already a member? Sign in.

 

or
Sign in to turn on 1-Click ordering.
 
   
More Buying Choices
26 used & new from $88.25

Have one to sell? Sell yours here
 
   
Pharmaceutical Medicine, Biotechnology and European Law
 
 
Please tell the publisher:
I’d like to read this book on Kindle

Don’t have a Kindle? Get yours here.
 
  

Pharmaceutical Medicine, Biotechnology and European Law (Hardcover)

by Richard Goldberg (Editor), Julian Lonbay (Editor) "This essay is not intended for specialists in intellectual property or European Community law..." (more)
Key Phrases: literature exemption, increased injury costs, double actionability rule, Member States, Council Directive, European Commission (more...)
No customer reviews yet. Be the first.

List Price: $120.00
Price: $120.00 & this item ships for FREE with Super Saver Shipping. Details
Special Offers Available
In Stock.
Ships from and sold by Amazon.com. Gift-wrap available.

Only 1 left in stock--order soon (more on the way).

Want it delivered Monday, October 13? Choose One-Day Shipping at checkout. See details

26 used & new available from $88.25

Special Offers and Product Promotions

  • Save $5 off $25, $10 off $50, or $15 off $100 when you pay with Bill Me Later®. Offer valid Oct 1, 2008 - Oct 12, 2008. Limited to items sold by Amazon.com. Subject to credit approval. One per customer. Enter code BMLDEALS at checkout. Here's how (restrictions apply)

Editorial Reviews

Review
"...the collection of essays in Pharmaceutical Medicine vividly portrays the tensions and sheer ambition and complexities of superimposing European-wide bodies and law on national markets and member states to create a European market in pharmeceutical medicine and biotechnology...a welcome contribution." Journal of Legal Medicine

Product Description
European law has been faced with increasingly complex issues emerging from rapid developments in pharmaceutical medicine and biotechnology. A team of distinguished European legal practitioners and academics reassess the impact of European law on health care and pharmaceutical law. The essays are grouped under four themes: free movement of goods and persons, competition and intellectual property; European drug regulation; biotechnology; and product liability and transnational health care litigation. This important study offers a valuable resource for the pharmaceutical and biotechnology industries, as well as legal academics and practitioners.

See all Editorial Reviews

Product Details